Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma.

CONCLUSIONS: Oncogenic mutations are present in NPC patients. The efficacy of targeted drugs on patients with the related oncogenic mutations requires further validation. PMID: 25963410 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/25963410?dopt=Abstract

Source: Chinese Journal of Cancer - May 14, 2015 Category: Cancer & Oncology Tags: Chin J Cancer Source Type: research